"A policy change whereby only one dose is given in COVID-19 recovered persons would appear to be reasonable and optimal." Dr. Peter McCullough argues that truly Covid-19 recovered (not just a positive PCR with high cycles and no symptoms) have the immunity for life as CDC could not provide a single case in evidence to the contrary. As well, SARS convalescents seem to maintain their immunity to this day. Conclusion: ANY jabbing (just 1, or 2+) is counter-indicated for the convalescents as they only bear the risk of adverse events with no benefits for it whatsoever. So, no, not reasonable and not optimal. Maybe to appease the demon? But the demon will not stop at just one, it will keep pushing for more after that, with much more vigour, as he smells the defeated soul.
Here is another example. The 1st dose of pfizer was given just days after patient-reported symptoms of covid. 20 days later the 2nd dose was given and the patient in his 30s who was otherwise healthy died just couple of days after the 2nd dose of multi-organ failure.
Interestingly, the patient’s PCR test was negative. Could be a couple of interpretations. One possibility is that the vaccine administered just after apparent recovery led to death. The second possibility is that the patient never actually had covid and simply died from vaccine injury.
"...his team has been able to replicate international findings that HEPARIN can block the transmission of COVID-19 and prevent infection.
The spray coats the nose but does not go down into the lungs. The researchers say it is cheap, easy to distribute and is expected to be effective against mutant strains of the virus including the Omicron variant.
"It won't matter if a new variant comes along, this drug will block that protein from infecting the cells," Professor Campbell said.
"I'm very confident that we can demonstrate that it will work, and people will be using this before they go to the shops and before they go to school."
"A policy change whereby only one dose is given in COVID-19 recovered persons would appear to be reasonable and optimal." Dr. Peter McCullough argues that truly Covid-19 recovered (not just a positive PCR with high cycles and no symptoms) have the immunity for life as CDC could not provide a single case in evidence to the contrary. As well, SARS convalescents seem to maintain their immunity to this day. Conclusion: ANY jabbing (just 1, or 2+) is counter-indicated for the convalescents as they only bear the risk of adverse events with no benefits for it whatsoever. So, no, not reasonable and not optimal. Maybe to appease the demon? But the demon will not stop at just one, it will keep pushing for more after that, with much more vigour, as he smells the defeated soul.
Here is another example. The 1st dose of pfizer was given just days after patient-reported symptoms of covid. 20 days later the 2nd dose was given and the patient in his 30s who was otherwise healthy died just couple of days after the 2nd dose of multi-organ failure.
Interestingly, the patient’s PCR test was negative. Could be a couple of interpretations. One possibility is that the vaccine administered just after apparent recovery led to death. The second possibility is that the patient never actually had covid and simply died from vaccine injury.
https://wwwnc.cdc.gov/eid/article/27/11/pdfs/21-1612.pdf
Since when do we ever “vaccinate” someone with positive titers? It makes no sense.
"...his team has been able to replicate international findings that HEPARIN can block the transmission of COVID-19 and prevent infection.
The spray coats the nose but does not go down into the lungs. The researchers say it is cheap, easy to distribute and is expected to be effective against mutant strains of the virus including the Omicron variant.
"It won't matter if a new variant comes along, this drug will block that protein from infecting the cells," Professor Campbell said.
"I'm very confident that we can demonstrate that it will work, and people will be using this before they go to the shops and before they go to school."
https://www.abc.net.au/news/2021-12-22/melbourne-researchers-trial-use-of-common-drug-to-combat-covid/100717224